Involvement of phospholipase D in oxidative stress-induced necrosis of vascular smooth muscle cells by 신지철
Involvement of phospholipase D in oxidative stress-induced necrosis of
vascular smooth muscle cells
Eun-Young Shina, Do Sik Minc, Ji-Cheol Shinc, Kyung-Sun Shina, Min-Soo Hyuna,
Kwon-Soo Had, Hun-Sik Kimb, Hee-Yul Ahnb, Eung-Gook Kima;*
aDepartment of Biochemistry, College of Medicine and Research Institute for Genetic Engineering, Chungbuk National University, San 48,
Gaesin-dong, Heungduk-ku, Cheongju 361-763, South Korea
bDepartment of Pharmacology, College of Medicine, Chungbuk National University, Cheongju 361-763, South Korea
cDepartment of Physiology, College of Medicine, The Catholic University of Korea, 505 Banpo-dong, Socho-gu, Seoul 137-701, South Korea
dBiomolecule Research Group, Korea Basic Science Institute, Taejon 305-333, South Korea
Received 29 September 2001; accepted 16 October 2001
First published online 30 October 2001
Edited by Veli-Pekka Lehto
Abstract Phospholipase D (PLD) has been associated with
necrosis. However, it is not clear whether PLD plays a causative
role in this cellular process. We investigated the role of PLD in
oxidative stress-induced necrosis of vascular smooth muscle cells
(VSMCs). Pervanadate (hydrogen peroxide plus orthovanadate)
but not hydrogen peroxide alone activated PLD in a dose- and
time-dependent manner. Exposure of VSMCs to pervanadate
resulted in necrosis. Pretreatment with butan-1-ol, a PLD
inhibitor, attenuated both pervanadate-induced necrosis and
increase of intracellular Ca2+. Removal of extracellular Ca2+
inhibited pervanadate-induced necrosis by 50%. These results
suggest that PLD activation mediates pervanadate-induced
necrosis of VSMCs, which is at least partly due to Ca2+
toxicity. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Phospholipase D (PLD) catalyzes the hydrolysis of phos-
pholipids, such as phosphatidylcholine, to phosphatidic acid
(PA) plus the head group. PLD is recognized as an important
component of signal transduction in a variety of cells and is
implicated in a wide range of pathophysiological processes
that include in£ammation, secretion, proliferation, di¡erentia-
tion, apoptosis, neuronal and cardiac stimulation, diabetes,
and the respiratory burst in neutrophils [1]. PLD is also re-
ported to be involved in cellular necrosis. Tumor necrosis
factor (TNF) induces two distinct modes of cell death, namely
necrosis and apoptosis [2]. During TNF-induced cell death,
cytosolic phospholipase A2 (cPLA2) and PLD are activated.
De Valck et al. [3] reported that PLD activation is speci¢cally
associated with TNF-induced necrosis, whereas cPLA2 activa-
tion is associated with early TNF-induced apoptosis. How-
ever, it is not clear whether PLD activation is a cause or a
consequence of necrosis.
It has been reported that pervanadate induces apoptosis in
HeLa cells and lymphoid cell lines [4,5]. Pervanadate-elicited
apoptosis involves the activation of caspases 3, 8 and 9 and
the induction of the mitochondrial pathway such as the in-
duction of mitochondrial permeability transition and the re-
lease of cytochrome c [4]. The activation of NF-UB showed
the pro- or anti-apoptotic function depending on the nature of
apoptotic stimulus. The increase in NF-UB activation by per-
vanadate-induced tyrosine phosphorylation also mediated the
proapoptotic activity of pervanadate [5]. In contrast, little is
known about the signaling pathway of necrosis, although the
necrotic pathway is considered distinct from the apoptotic
pathway. In a previous study, we found that H2O2 or vana-
date alone was not an e¡ective stimulator of PLD [6]. Prein-
cubation of cells with higher concentrations of H2O2 alone
mostly induced apoptotic cell death [7]. In contrast, combined
treatment of H2O2 plus vanadate (pervanadate) resulted in a
marked elevation of PLD activity in Swiss 3T3 ¢broblasts [6].
These pervanadate-treated cells exhibited rapid morphological
changes such as shrinkage and £oating from the bottom of a
culture dish less than 1 h following exposure to pervanadate.
Thus, it is likely that pervanadate may induce a di¡erent type
of cell death, namely necrosis. Given that, treatment of pri-
mary cultured cells such as vascular smooth muscle cells
(VSMCs) with pervanadate may be a good model system to
explore a relationship between cellular necrosis and PLD.
In the present study, we show that when stimulated with
pervanadate, a strong activator of PLD, VSMCs underwent
necrosis but not apoptosis. In addition, we, for the ¢rst time,
demonstrate that the activation of PLD has a causal relation
with VSMC necrosis. Our results suggest that oxidative stress-
induced necrosis of VSMCs may be a critical event in the
progression of several cardiovascular diseases such as ische-
mia^reperfusion (I/R) injury and rupture of atherosclerotic
plaques.
2. Materials and methods
2.1. Materials
Hydrogen peroxide and sodium orthovanadate were purchased
from Sigma Chemical Co. (St. Louis, MO, USA). Thin layer chroma-
tography plates and phosphatidylbutanol (PtdBut) standard were ob-
tained from Whatman and Avanti Polar Lipids, Inc. (Alabaster, AL,
USA). Ca2-free medium was purchased from Gibco BRL (Rockville,
MD, USA).
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2.2. Cell culture
VSMCs were obtained by collagenase digestion of aortas from
7-week-old Sprague^Dawley rats [8]. Cultured VSMCs showed the
characteristic ‘hills and valleys’ growth pattern. VSMC purity was
con¢rmed by immuno£uorescence using smooth muscle-speci¢c anti-
actin antibody. VSMCs at six to nine passages were used for experi-
ments.
2.3. Measurement of PLD activity in VSMC
PLD activity was assessed by measuring the formation of
[3H]PtdBut [6]. Brie£y, VSMCs were serum-starved in Dulbecco’s
modi¢ed Eagle’s medium for 24 h before the start of the assay. For
the ¢nal 20 h of serum starvation, the cells were labeled with 1 WCi/ml
[9,10-3H]myristic acid. During the ¢nal 10 min of the preincubation,
0.3% butan-1-ol was included. At the end of the preincubation, cells
were treated with 0.1 mM Na3VO4 for 20 min and then stimulated
with the various concentrations of H2O2 for the indicated times. The
radioactivity incorporated into total phospholipids was measured, and
the results are presented as a percentage of the total counts per minute
incorporated into PtdBut.
2.4. Detection of apoptosis and necrosis by acridine orange
(AO)^ethidium bromide (EtBr) staining
Cells were cultured on poly-L-lysine-coated coverslips, and treated
with either pervanadate for 30 min or 0.5 WM staurosporine for 24 h
in the presence of 0.1% fetal bovine serum to control cellular apopto-
sis [9], followed by washes with PBS. Cells were then ¢xed with 4%
paraformaldehyde in 0.1% Triton X-100 for 20 min and washed three
times with 0.02 M glycine/PBS. Next, cells were incubated with stain-
ing solution (5 Wg/ml AO, 5 Wg/ml EtBr and 0.5 mg/ml RNase A) at
37‡C for 1 h and then washed ¢rst, three times with 0.1% Triton
X-100/PBS and then, three times with PBS. Finally, cell £uorescence
was determined using laser confocal microscopy (Bio-Rad Laborato-
ries, Richmond, CA, USA).
2.5. Flow cytometry
Cell death was assessed using the Annexin-V-FITC apoptosis de-
tection kit (Roche Molecular Biochemicals, Germany). Following per-
vanadate treatment, VSMCs were incubated in labeling solution (10
mM HEPES, pH 7.4, 140 mM NaCl, and 5 mM CaCl2) containing
1 Wg/ml propidium iodide (PI) and 20 Wl annexin-V-FITC for 15 min.
Cell death was then determined by FACS Calibur (Becton Dickinson,
Franklin Lakes, NJ, USA).
2.6. Measurement of intracellular Ca2+ ([Ca2+]i)
Changes in [Ca2]i were monitored using laser scanning confocal
microscopy (Carl Zeiss LSM 410, Jena, Germany) as described pre-
viously [10]. Brie£y, cells were grown on round coverslips in multi-
well culture plates and incubated with 4 mM £uo 3-AM in serum-free
medium for 1 h. Each coverslip containing stained cells was placed in
a perfusion chamber, and then scanned every 5 s with an argon laser
with an excitation wavelength of 488 nm. The emitted £uorescence
was detected at a 515-nm wavelength. All images from the scanning
were processed to determine [Ca2]i changes at the level of a single
cell.
2.7. Statistics
Statistical analyses were performed using the SAS System for Win-
dows (release 6.12). [Ca2]i measurement data were subjected to Wil-
coxon rank-sum test and the statistical signi¢cance was set at
P6 0.05.
3. Result and discussion
3.1. Dose- and time-dependent activation of PLD by
pervanadate
It has been reported that oxidative stress stimulates PLD.
However, H2O2 alone did not a¡ect PLD activity signi¢-
cantly. To determine whether addition of vanadate to H2O2
(pervanadate) stimulates PLD, growth-arrested VSMCs were
labeled with [3H]myristate, incubated with 0.3% butan-1-ol,
and exposed to varying concentrations of H2O2 for 30 min
following pretreatment with 0.1 mM Na3VO4. PLD activity
was determined by measuring the formation of [3H]PtdBut.
Pervanadate-stimulated formation of [3H]PtdBut was dose-de-
pendent, reaching a peak at 0.5^1 mM H2O2 (Fig. 1A). Thus,
in the following experiments, the agonist condition for PLD
activation was ¢xed as 0.5 mM H2O2 plus 0.1 mM Na3VO4.
PLD activity continued to increase for up to 50 min (Fig. 1B).
These results indicate that exogenous pervanadate activates
PLD in a time- and dose-dependent manner in VSMCs.
3.2. Induction of VSMC necrosis by pervanadate
Pervanadate has been shown to induce apoptosis in HeLa
cells and lymphoid cell lines [4,5]. To determine whether per-
vanadate treatment results in necrosis or apoptosis, VSMCs
were examined for morphological changes and subjected to
£ow cytometric (FACS) analyses after double staining with
annexin-V and PI (Fig. 2). Cells were exposed to pervanadate
for 30 min or to 0.5 WM staurosporine for 24 h (apoptotic
control) [9]. In phase contrast microscopy, staurosporine-
treated cells exhibited morphological features of apoptosis
(i.e. condensation of nuclear chromatin and nuclear fragmen-
tation), while pervanadate-treated cells frequently showed dis-
Fig. 1. Dose- and time-dependence of pervanadate-stimulated PLD
activation in VSMCs. For the PLD assay, growth-arrested VSMCs
were radiolabeled with [3H]myristate, pretreated with 0.1 mM vana-
date for 20 min, stimulated with the indicated concentrations of
H2O2 for 30 min (A) or with 0.5 mM H2O2 for the indicated times
(B), and then the radioactivity incorporated into PtdBut was mea-
sured. Data represent the results of three separate experiments.
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ruption of cytoplasmic membrane and nuclear lysis (arrow-
heads in Fig. 2A). Changes in nuclear events were further
investigated by laser confocal microscopy following staining
with AO and EtBr (Fig. 2B). Untreated control cells were
di¡usely stained green and the size of the cells were much
larger than that of pervanadate- or staurosporine-treated cells.
This ¢nding is consistent with the results from phase contrast
microscopy. Some nuclei of pervanadate-treated cells were
orange in color (AO/EtBr), typical of necrosis (arrowheads
in Fig. 2B). Staurosporine-treated cells revealed a character-
istic of apoptosis, fragmented nuclei of bright green (AO/
EtBr) (arrows in Fig. 2B). Finally, FACS analysis demon-
strated that 20% of the staurosporine-treated cells appeared
in the lower right quadrant (annexin-V/PI3), which is con-
sistent with the nature of staurosporine as an apoptotic agent
(Fig. 2C). By contrast, pervanadate treatment resulted in a
di¡erent pattern. Approximately 20 and 8% of the cells were
observed in the upper right quadrant (annexin-V/PI) and in
the upper left quadrant (annexin-V3/PI), respectively, where-
as the cells in the lower right quadrant (annexin-V/PI3) took
an insigni¢cant fraction of the populations. Most of the un-
stimulated control cells accumulated in the lower left quad-
rant. We further examined the time course of VSMC necrosis,
since necrosis is one end of a spectrum of cell death in which
apoptosis occurs rapidly. Necrotic cells markedly increased
over the time course of 4 h after pervanadate treatment
(Fig. 2D). No signi¢cant changes in the percentage of cells
in the lower right quadrant (apoptosis) at 2 h were seen com-
pared with that at the zero time control. Even at later time
points of 4 h, proportion of early apoptotic cells was negli-
gible. This excludes a possibility that necrosis is a passive end
product of apoptosis. Taken together, these results indicate
that pervanadate-treated VSMCs undergo necrosis rather
than apoptosis.
Fig. 2. Morphological features and FACS analysis of pervanadate- or staurosporine-treated VSMCs. VSMCs were either not treated (control),
treated with pervanadate (0. 5 mM H2O2 plus 0.1 mM vanadate) as described in Fig. 1, or with 0.5 WM staurosporine for 24 h in the presence
of 0.1% fetal bovine serum (staurosporine) and then visualized by phase contrast microscopy (100U) (A), or laser confocal microscopy (400U)
following double staining with AO (5 Wg/ml) and EtBr (5 Wg/ml) (B), or they were analyzed by FACS following double staining with annexin-
V-FITC and PI (C). Cells were stimulated for the indicated times and then analyzed by FACS (D). Scale bar: 50 Wm.
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3.3. Involvement of PLD in pervanadate-induced
VSMC necrosis
We next examined whether PLD is involved in pervanadate-
induced necrosis of VSMCs. In recent studies, primary alco-
hols such as butan-1-ol or propanol have been used to inhibit
PLD-induced cellular events [11,12]. In the presence of these
alcohols, PLD catalyzes a transphosphatidylation reaction,
thus forming phosphatidylalcohol instead of PA. No signi¢-
cant change was observed in cells pretreated with butan-1-ol
alone compared to the untreated cells (Fig. 3a,b, top panels).
Approximately 22% of VSMCs showed necrosis in response to
pervanadate, whereas the proportion of early apoptotic cells
(lower right quadrant) was negligible (Fig. 3c). Pretreatment
with butan-1-ol rescued the pervanadate-induced necrosis in a
dose-dependent manner (Fig. 3d^g and closed circle in the
bottom panel), thus indicating that PLD is involved in this
process. Maximal inhibition was achieved at a butan-1-ol con-
centration of 0.3% Butan-2-ol, which is not as e¡ective as
butan-1-ol as a PLD substrate in the formation of PtdBut,
did not protect against pervanadate-induced necrosis (Fig. 3,
open circle), suggesting that PLD inhibition by butan-1-ol is
therefore speci¢c. These results suggest that pervanadate-in-
duced VSMC necrosis is mediated by PLD. One of the major
e¡ects of pervanadate on the cellular proteins is to induce
tyrosine phosphorylation. PLD is tyrosine-phosphorylated
by pervanadate in a time- and dose-dependent manner [6].
Tyrosine phosphorylation of PLD, however, seems to be re-
lated with necrosis. It is therefore tempting to speculate that
the nature of tyrosine-phosphorylated proteins may determine
the cellular fate following exposure to pervanadate. However,
it remains to be further clari¢ed how pervanadate functions as
a necrotic or an apoptotic agent.
3.4. E¡ect of Ca2+ on pervanadate-induced necrosis
of VSMCs
Pervanadate causes mobilization of [Ca2]i in various cell
types, although it is not apparent that pervanadate is involved
in Ca2 in£ux [13^15]. PLD-catalyzed products of phosphati-
dylcholine are PA and choline. PA is considered a major
mediator of PLD-induced biological events. Recent studies
suggest a role of PA for increase in [Ca2]i concentration
[16,17]. Thus, accumulation of higher levels of PA by perva-
nadate-induced PLD activation may exert cytotoxic e¡ect
through a persistent increase in [Ca2]i. We therefore exam-
ined the possibility that pervanadate-induced VSMC necrosis
may be mediated by a sustained Ca2 increase. A typical
tracing of [Ca2]i in single cells showed that pervanadate
treatment caused a slow initial rise, followed by a sustained
phase, which gradually declined to a basal level (Fig. 4A, top
panel). This result is consistent with a previous study in hu-
man T cells [13]. Preincubation of cells with butan-1-ol alone
did not in£uence [Ca2]i (data not shown). However, butan-1-
ol signi¢cantly in£uenced the pervanadate-induced [Ca2]i re-
sponse during the sustained phase, where the level gradually
decreased to half that of the control at 11 min (Fig. 4A). The
peak level was only slightly a¡ected. We further examined
whether the in£ux of Ca2 is directly involved in pervana-
date-induced necrosis using FACS analysis. As illustrated in
Fig. 4B, in the absence of extracellular Ca2, the percentage
of necrotic cells decreased by 50% compared to that from cells
cultured in Ca2-containing medium. These results indicate
that the major cytotoxic e¡ect of pervanadate on VSMC is
Fig. 3. E¡ect of butan-1-ol or butan-2-ol on pervanadate-induced
necrosis of VSMCs. Quiescent VSMCs were pretreated with the in-
dicated concentrations of butan-2-ol (open circle, bottom panel) or
butan-1-ol (closed circle) for 1 h prior to stimulation with pervana-
date for 30 min. Cells were then processed for FACS analysis. Cells
in the upper left and the upper right quadrant were determined as
necrotic ones. a: negative control without pervanadate; b: butan-1-
ol (0.3%) without pervanadate; c: positive control with pervana-
date; d: 0.05% butan-1-ol plus pervanadate; e: 0.1% butan-1-ol
plus pervanadate; f : 0.2% butan-1-ol plus pervanadate; and g: 0.3%
butan-1-ol plus pervanadate. Results represent the data from three
independent experiments.
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due at least in part to the in£ux of extracellular Ca2, in
which PLD is involved.
Evidence indicates that cell death occurs in I/R injury and
athrosclerotic plaques, which are characterized by accumula-
tion of oxidative stress [18,19]. Lipid oxidation products such
as oxidized low-density lipoprotein (LDL) have been consid-
ered prime candidates for inducing cellular necrosis [20]. Re-
cent studies showed that oxidized LDL stimulates PLD, and
this activation is downstream of tyrosine phosphorylation
[21]. Pervanadate also induces tyrosine phosphorylation of
cellular proteins including PLD. Taken together, it is likely
that an intermittent attack of excessive oxidative stress, as
shown in this study, and oxidized LDL contribute to cellular
necrosis via tyrosine phosphorylation^PLD pathway, which
may cause I/R injury and abrupt plaque rupturing. In con-
clusion, considering the recent discovery of the potential role
of oxidative stress in cell signaling, we have demonstrated that
pervanadate can induce cellular necrosis by modulating intra-
cellular signal pathways. This occurs via the activation of
PLD. Therefore, speci¢c inhibition of PLD may represent a
potential therapeutic modality for preventing vascular dys-
function in the aforementioned diseases.
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Fig. 4. E¡ect of Ca2 on pervanadate-induced necrosis of VSMCs.
A: VSMCs were preincubated with bu¡er alone (Control) or with
0.3% butan-1-ol (Butan-1-ol) for 30 min prior to stimulation with
pervanadate. In the top panel, representative tracings of [Ca2]i in
the normal medium are depicted. In the bottom, [Ca2]i during the
peak (5 min after pervanadate stimulation) and the sustained phase
(8 min and 11 min after pervanadate stimulation) are shown. Each
value represents the mean þ S.D. (n = 5 cells) for three independent
experiments. *P6 0.05 compared to the pervanadate-treated control.
Open bars (C), control; black bars (B), 0.3% butan-1-ol. B: Cells in
the normal or Ca2-free medium were stimulated with pervanadate,
and then analyzed by FACS as described in Fig. 2. Percentage of
necrotic cells occurring in the absence of extracellular Ca2 is pre-
sented relative to the control value (100%) in the presence of Ca2.
Results represent the data from three independent experiments.
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